My understanding of the FDA's stance is that the approval of the Registration study will hinge on the outcomes and data from the Phase 2 study. SYC has indicated that results from the study will be consistently disclosed, and that extensive preparations, including the manufacturing processes required for Registration approval, have been undertaken.
- Forums
- ASX - By Stock
- Ann: March 2024 Quarterly Update and Appendix 4C
My understanding of the FDA's stance is that the approval of the...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
3.9¢ |
Change
-0.004(9.30%) |
Mkt cap ! $31.40M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 3.9¢ | $140.0K | 3.509M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 41376 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 200000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 112136 | 0.039 |
4 | 331500 | 0.038 |
8 | 396864 | 0.037 |
2 | 575000 | 0.036 |
5 | 389304 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 200000 | 3 |
0.041 | 915821 | 5 |
0.042 | 250000 | 3 |
0.043 | 421000 | 2 |
0.045 | 74950 | 2 |
Last trade - 13.48pm 12/09/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |